Thesis (M.Sc.)--York University, 2006. Graduate Programme in Chemistry. / Typescript. Includes bibliographical references (leaves 123-137). Also available on the Internet. MODE OF ACCESS via web browser by entering the following URL: http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&res_dat=xri:pqdiss&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&rft_dat=xri:pqdiss:MR19750

<p> Dihydrofolate reductase from a subline of the L1210 lymphoma was purified by affinity chromatography using substituted Sepharose -4B to which was coupled methotrexate, a specific, tight binding inhibitor of the enzyme. The purified enzyme was subjected to disc gel electrophoresis at pH 8.5. At least two bands of activity were detected on the gel by the formation of a reduced formazan. Their ratios were dependent on enzyme concentration. Similar bands were found in the presence of EDTA (10^-6M), 4M and SM urea. When a substrate, NADPH (5xl0^-5M), was added to the buffers used in electrophoresis, three bands of enzyme activity were present in a fixed ratio which was independent of enzyme concentration. Protein bands showed a different but constant ratio. When folate replaced dihydrofolate as substrate in the assay mixture, the bands of activity corresponded at high concentrations of the enzyme. When activity was detected in the presence of an increasing concentration of methotrexate, different inhibition of the bands resulted. Preliminary experiments with crude extracts of the same subline gave activity profiles with multiple peaks.</p> / Thesis / Master of Science (MSc)

No description available.

No description available.

Les biomolécules sont naturellement immergées dans l’eau, qui joue un rôle clé dans de nombreux processus biologiques. Réciproquement, les propriétés de l’eau sont affectées par la présence de la biomolécule. Dans cette thèse, nous combinons modèles théoriques et simulations numériques pour obtenir une description à l’échelle moléculaire des interactions entre une biomolécule et son environnement. Le manuscrit est structuré en deux parties, abordant deux aspects complémentaires de cette interaction complexe. La première partie est consacrée à la perturbation induite par une biomolécule sur l’eau. Nous déterminons en quoi la couche d’hydratation diffère de l’eau bulk et identifions les facteurs moléculaires en jeu. Nous comparons ensuite les couches d’hydratation d’une protéine antigel et d’une protéine modèle afin de déterminer si les propriétés d’hydratation peuvent expliquer l’activité antigel. Nous étudions enfin la dynamique d’hydratation de l’ADN. Nous obtenons une image résolue spatialement des propriétés de sa couche d’hydratation et y caractérisons les différentes sources d’hétérogénéité. La deuxième partie s’intéresse au rôle de l’environnement sur la catalyse enzymatique. Nous étudions deux systèmes distincts, avec des questions différentes mais une même méthodologie. Nous examinons d’abord le rôle de résidus dans le site actif de la dihydrofolate réductase et obtenons une interprétation moléculaire de résultats expérimentaux récents. Enfin, nous nous intéressons à la catalyse enzymatique en solvant organique, où l’addition de petites quantités d’eau permet d’accélérer la réaction. Nous recherchons une description à l’échelle moléculaire de cet effet. / Biomolecules are immersed in an aqueous solvent, which plays a key role in a wide range of biochemical processes. In addition, the properties of water molecules in the hydration shell are perturbed by the presence of the biomolecule. In this thesis, we combine theoretical models and numerical simulations to provide a molecular description of the interplay between a biomolecule and its environment. The manuscript is structured in two parts, addressing two complementary aspects of this complex interaction. In the first part we focus on the perturbation induced by a biomolecule on water molecules. We determine how much the hydration shell differs from bulk water and we identify the molecular factors at play. We then compare the hydration shells of an antifreeze protein and of a typical protein and investigate whether the shell structure and dynamics can explain the antifreeze properties. We finally study the hydration dynamics of a DNA dodecamer where slow water dynamics was suggested. We obtain a spatially resolved picture of DNA hydration and investigate the sources of heterogeneity. In the second part we examine the role of the environment in the chemical step of enzyme catalysis. We focus on two distinct systems with different questions, but relying on a common simulation methodology. We first examine the role of specific active site residues in catalysis by dihydrofolate reductase and we provide a molecular interpretation of recent experimental results. We finally study the role of water in enzyme catalysis in organic solvents, where addition of small amounts of water was shown to accelerate the chemical step. We seek a molecular scale description of this effect.

This thesis presents an effort to understand the C-H-C transfer in enzymatic reactions from the comparison of different variants of enzymes that have unrelated protein sequences and structures, but catalyze the same chemical transformation. I evaluated the kinetic isotope effects (KIEs) and their temperature dependences and interpreted the findings in accordance with Marcus-like models. The enzyme system studied is dihydrofolate reductase (DHFR), which catalyzes the reduction of 7,8-dihydrofolate (H2F) to 5,6,7,8-tetrahydrofolate (H4F) using reduced β-nicotinamide adenine dinucleotide 2' phosphate (NADPH) as a reducing agent. H-transfer reactions in typical enzymes from three genetically unrelated families, E. coli chromosomal DHFR (cDHFR, FolA), plasmid coded R67 DHFR (FolB), and pteridine reductase 1 (PTR1, FolM) were comparatively investigated. Chapter I provides a brief introduction to the thesis. Chapter II presents optimized procedures for a one-pot, enzymatic microscale synthesis of several NADPH isotopologues used in KIE experiments. Chapter III focuses on the application of novel competitive primary H/D KIE determinations. Chapter IV compares the H-transfer reactions between primitive R67 DHFR and the chromosomal DHFR, and Chapter V describes the investigation of H-transfer reactions at high and low ionic strengths with theoretical and experimental approaches in order to understand the unusual enhancement in H-transfer rate of R67 DHFR with increasing ionic strength. Chapter VI discusses an improved PTR1 purification procedure and comparisons of steady state kinetic parameters using PTR1 and cDHFR with H2F and dihydrobiopterin (H2B) substrates. Thus, the investigation of the H-transfer reaction catalyzed by cDHFR with an unnatural substrate, H2B is described. Finally, a summary is provided and future directions are discussed in Chapter VII.

No description available.

No description available.

The main objective of the research described in this thesis has been the design and synthesis of inhibitors of the enzyme dihydrofolate reductase (DHFR) intended for local administration and devoid of systemic side-effects. The blocking of the enzymatic activity of DHFR is a key element in the treatment of many diseases, including cancer, bacterial and protozoal infections, and also opportunistic infections associated with AIDS (Pneumocystis carinii pneumonia, PCP). Recent research indicates that the enzyme also is involved in various autoimmune diseases, e.g., rheumatoid arthritis, inflammatory bowel diseases and psoriasis. Many useful antifolates have been developed to date although problems remain with toxicity and selectivity, e.g., the well-established, classical antifolate methotrexate exerts a high activity but also high toxicity. The new antifolates described herein were designed to retain the pharmacophore of methotrexate, but encompassing an ester group, so that they also would serve as substrates for the endogenous hydrolytic enzymes, e.g., esterases. Such antifolates would optimally comprise good examples of soft drugs because they in a controlled fashion would be rapidly and predictably metabolized to non-toxic metabolites after having exerted their biological effect at the site of administration. A preliminary screening of a large series of simpler aromatic esters as model compounds in a biological assay consisting of esterases from different sources was performed. The structural features of the least reactive ester were substituted for the methyleneamino bridge in methotrexate to produce analogues that were chemically stable but potential substrates for DHFR as well as for the esterases. The new inhibitor showed desirable activity towards rat liver DHFR, being only eight times less potent then methotrexate. Furthermore, the derived metabolites were found to be poor substrates for the same enzyme. The new compound showed good activity in a mice colitis model in vivo, but a pharmacokinetic study revealed that the half-life of the new compound was similar to methotrexate. A series of compounds characterized by a high lipophilicity and thus expected to provide better esterase substrates were designed and synthesized. One of these analogues in which three methoxy groups were substituted for the glutamic residue of methotrexate exhibited favorable pharmacokinetics. This compound is structurally similar to another potent DHFR inhibitor, trimetrexate, used in the therapy of PCP (vide supra). The new inhibitor that undergoes a fast metabolism in vivo is suitable as a model to further investigate the soft drug concept.

Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Biochemical Sciences Candidate: Kateřina Šedivá Supervisor: Mgr. Eva Novotná, Ph.D. Title of diploma thesis: Cloning, expression and purification of mycobacterial dihydrofolate reductase Dihydrofolate reductase is an enzyme essential for the metabolism of folic acid - it catalyzes the reduction of dihydrofolate to tetrahydrofolate. Tetrahydrofolate is an important cofactor involved in one-cabron transfer reactions. Dihydrofolate reductase plays a key role in the synthesis of DNA, RNA and proteins. Dihydrofolate reductase was also found in M. tuberculosis. This bacterium is the most common causative agent of tuberculosis in humans. Thus dihydrofolate reductase could be a potential target for the design of new antituberculotics. The recombinant protein dihydrofolate reductase was prepared in several steps. The coding sequence of the protein was first amplified by polymerase chain reaction. A recombinant plasmid, obtained by the ligation of an amplified segment of DNA with plasmid pET-28b(+), was transformed into competent cells E. coli strain BH101 by the heat shock method. Cells E. coli strain BL21(DE3) were used for the protein expression. The expression was induced by the addition of isopropyl-β-D-...